Important OptumRx updates to support providers, clinical staff and patients through COVID-19.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 3, 2017 – Teva announced the FDA approval of Austedo (deutetrabenazine) for the treatment of chorea associated with Huntington’s disease (HD).
Download PDF
Return to publications
